2-Methyl-1-ethyl-Δ²-tetrahydropyrimidin | 4271-97-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 2-Methyl-1-ethyl-Δ²-tetrahydropyrimidin
• 英文别名: 1-ethyl-2-methyl-1,4,5,6-tetrahydro-pyrimidine；1-Ethyl-1,4,5,6-tetrahydro-2-methylpyrimidine；1-ethyl-2-methyl-5,6-dihydro-4H-pyrimidine
• CAS: 4271-97-0
• 化学式: C₇H₁₄N₂
• 分子量: 126.202
• InChiKey: SCBRJAHMOLUGRP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  15.6
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-Methyl-1-ethyl-Δ²-tetrahydropyrimidin 在 硫酸 作用下， 150.0 ℃ 、980.6 kPa 条件下， 生成 N-Ethyl-N'-(2-methyl-2-hydroxyethyl)-propylendiamin
  参考文献：
  名称：

  Magosch,K.-H.; Feinauer,R., Justus Liebigs Annalen der Chemie, 1970, vol. 742, p. 128 - 134

  摘要：

  DOI：

文献信息

• Synthesis of 1,1-diamino-2-thioacylethylenes: A novel C-thioacylation by the Willgerodt-Kindler reaction
  作者：S. Rajappa、M.D. Nair、R. Sreenivasan、B.G. Advani

  DOI：10.1016/0040-4020(82)80145-2

  日期：1982.1

  A novel C-thioacylation reaction is described. Reaction of aromatic or heterocyclic aldehydes with 1-alkyl-2-methyl-1,4,5,6-tetrahydropyrimidine or 1-alkyl-2-methylimidazolidine in the presence of sulphur leads to the thioacylketeneaminals 6, 10 or 12 in low to moderate yields. The structure of 6e was proved by S-methylation to 7e and acid-hydrolysis to the known 8e. Oxidative cyclization of 6 leads

  描述了新颖的C-硫酰化反应。与硫引线的存在对thioacylketeneaminals 1-烷基-2-甲基-1,4,5,6-四氢嘧啶或1-烷基-2-甲基咪唑芳族或杂环醛的反应6，10或12中低到中等产量。通过S-甲基化为7e并酸水解为已知的8e证明了6e的结构。6的氧化环化导致异噻唑并[2,3- a ]嘧啶鎓盐13。
• Inhibitors of factor Xa
  申请人：Millennium Pharmaceuticals, Inc.

  公开号：US20040116399A1

  公开（公告）日：2004-06-17

  Novel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.

  本发明揭示了一种具有对哺乳动物因子Xa活性的新化合物、其盐和相关组合物。这些化合物在体外或体内用于预防或治疗凝血障碍。
• BENZAMIDES AND RELATED INHIBITORS OF FACTOR XA
  申请人：Zhu Bing-Yan

  公开号：US20090131411A1

  公开（公告）日：2009-05-21

  Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.

  本发明涉及一种新型苯甲酰胺类化合物，包括其药学上可接受的异构体，盐，水合物，溶剂合物和前药衍生物，具有对哺乳动物因子Xa的活性。本发明还涉及含有这种化合物的组合物。这些化合物和组合物在体内或体外用于预防或治疗凝血障碍。
• Benzamides and related inhibitors of factor Xa
  申请人：Zhu Bing-Yan

  公开号：US20070021472A1

  公开（公告）日：2007-01-25

  Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.

  本发明涉及一种新型苯甲酰胺类化合物，包括其药学上可接受的异构体、盐、水合物、溶剂合物和前药衍生物，其对哺乳动物因子Xa具有活性。本发明还描述了含有这种化合物的组合物。这些化合物和组合物在体外或体内用于预防或治疗凝血障碍。
• CURABLE-ON-DEMAND COMPOSITION COMPRISING DUAL REACTIVE SILANE FUNCTIONALITY
  申请人：Yang Yu

  公开号：US20130178553A1

  公开（公告）日：2013-07-11

  A curable composition comprises (a) at least one inorganic or organic compound comprising reactive silane functionality comprising at least one hydrosilyl moiety; (b) at least one inorganic or organic compound comprising reactive silane functionality comprising at least one hydroxysilyl moiety, the hydroxysilyl moiety optionally being generated in situ by hydrolysis of at least one hydrosilyl moiety; and (c) at least one photoactivatable composition that, upon exposure to radiation, generates at least one base selected from amidines, guanidines, phosphazenes, proazaphosphatranes, and combinations thereof; with the proviso that, when component (a) is an organic polymer, then component (b) is different from component (a) and is not generated in situ by hydrolysis of component (a).

  一种可治愈的组合物包括：（a）至少一种含有反应性硅烷官能团的无机或有机化合物，其中硅烷官能团包括至少一个氢硅烷基；（b）至少一种含有反应性硅烷官能团的无机或有机化合物，其中硅烷官能团包括至少一个羟基硅烷基，羟基硅烷基可以通过至少一个氢硅烷基的水解而在原位生成；以及（c）至少一种光活性组合物，当暴露于辐射下时，生成至少一种从氨基甲酸酰胺、鸟嘌呤、磷氮烷、丙氨酸磷酸酯和其组合物中选择的碱，前提是当组分（a）是有机聚合物时，组分（b）与组分（a）不同，并且不是通过组分（a）的水解在原位生成的。